LATTICEFLOW-AI
1.2.2024 14:01:33 CET | Business Wire | Press release
LatticeFlow AI, the leading Artificial Intelligence (AI) platform for enabling enterprises to build performant, safe, and trustworthy AI systems at scale, today announced the appointment of Tom Ulrich as Senior Vice President and General Manager for North America. More recently, Tom served as Vice President of Sales, Financial Services at C3.AI, where he played a key role in launching the company’s AI banking business which led to a successful IPO in 2019 (NYSE:AI).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240201601542/en/
(Graphic: Business Wire)
Tom’s appointment follows LatticeFlow AI’s strategic expansion into the US market. With over 25 years of experience, Tom has proven expertise in building and developing world class sales teams for high-growth enterprise SaaS companies.
“Tom brings unmatched expertise in scaling early to mid-stage tech companies into hyper-growth phases. At LatticeFlow AI, Tom will play a vital role in accelerating our growth trajectory by identifying strategic business opportunities and driving revenue growth in the North American market,” said Petar Tsankov, CEO & Co-founder of LatticeFlow AI.
Earlier in his career, Tom held various sales leadership roles at MicroStrategy, where he helped grow the company from $20 million to $500 million, culminating in a successful IPO (NASDAQ:MSTR). Throughout his professional journey, Tom has remained steadfast in his dedication to helping clients unlock business value through data-driven insights.
"As AI becomes increasingly integral in our daily lives, ensuring model trust, safety, and a positive societal impact is more important than ever. I’m excited and honored to join the LatticeFlow AI team, collaborating with some of the best AI engineers in the world who are focused on tackling these challenges. I look forward to helping our customers harness the power of AI, while accelerating model performance and safety,” said Tom Ulrich.
“Tom joining LatticeFlow AI serves as yet another testimonial to the Company’s ability to attract world-class talent,” stated Andre Boisvert, Chairman of LatticeFlow AI. “Tom’s extensive experience in building global sales teams across five distinct enterprise software companies, with a particular focus on predictive analytics and AI, underscores his invaluable potential for propelling LatticeFlow AI's advancement.”
Tom received an MBA from George Washington University with a major in International Business and is based in Vienna, VA.
About LatticeFlow AI
Founded by world renowned AI researchers from ETH Zurich, LatticeFlow AI enables enterprise companies to develop production-ready machine learning models at scale. By systematically identifying and fixing model and data issues at scale, we help enterprises unlock the true potential of AI. Additionally, we offer a comprehensive technical AI assessment to assist enterprises achieve regulatory compliance, reliability and robustness for their mission-critical AI applications. LatticeFlow AI has won several awards including the AI Privacy Challenge in April 2023, followed by the Swiss AI Award and the US Army Global AI Award.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240201601542/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers17.7.2026 19:10:00 CEST | Press release
Rapid oral presentations will highlight new Phase 1 data across Incyte’s solid tumor portfolioBoth INCB161734, an investigational, potent, selective and orally bioavailable KRAS G12D inhibitor, and INCA338901, a TGFβR2×PD-1 bispecific antibody, are being evaluated in ongoing Phase 3 programs as first-line treatments for patients with advanced pancreatic ductal adenocarcinoma (PDAC) and microsatellite stable (MSS) colorectal cancer, respectively Incyte (Nasdaq:INCY) today announced that it will highlight data from several programs in its oncology portfolio in six presentations at the European Society of Medical Oncology (ESMO) Congress 2026, being held October 23 - 27, 2026, in Madrid. “The data at ESMO will further illustrate Incyte’s commitment to advancing innovation for patients with cancer,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Among the presentations are important updates from our KRAS G12D inhibitor in advanced pancreatic ca
STL Expands Its Optical Connectivity Portfolio in the US with the CONCAT Solution17.7.2026 14:24:00 CEST | Press release
STL Optical Connectivity NA, LLC, (STLOC), a U.S. subsidiary of STL (Sterlite Technologies Ltd.) [NSE: STLTECH], a leading connectivity solutions provider for AI-ready digital infrastructure, today announced that it launched its new advanced FTTH solution, CONCAT, after successfully completing field trials on the networks of one of the largest telecom service providers in the United States. Following successful field validation, CONCAT is now available to digital infrastructure providers seeking faster fiber rollouts with reduced deployment complexity and labor. It enables up to 71% in labor cost savings by eliminating most field splicing through factory-assembled, pre-connectorized fiber segments that deliver plug-and-play installation. CONCAT simplifies fiber deployment by shifting critical fiber preparation and termination into a controlled manufacturing environment ensuring consistent quality, faster installation, and lower operational risk in the field. CONCAT solution is ideal fo
Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press release
A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023 Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, devel
China's ~$900B Live-Commerce Market Now Approaches US E-Commerce Scale17.7.2026 12:30:00 CEST | Press release
The consumer habits reshaping global retail were built in the East — and most Western shoppers haven't yet adopted them. NIQ report shows that brands still treating live, social, and quick commerce as "emerging" risk being left behind. The center of gravity in global retail has shifted East. The formats now driving the fastest growth in global retail (live shopping, social commerce, and delivery in minutes) were pioneered and scaled in Asia, and most Western consumers have yet to adopt them. According to NIQ (NYSE: NIQ), a leading consumer intelligence company, in its global report The Commerce Revolution: Where East Meets West, the gap between East and West is still vast. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717253489/en/ China´s USD 900bn live shopping boom now approaches the scale of the US E-commerce The scale is already substantial. China's live-commerce market alone was worth roughly $900 billion in 2025,
Ant International’s Alipay+ Connects Argentina's National QR Payment Scheme via PVS,Enabling for Cross-Border Digital Payment Nationwide at Millions of Merchants17.7.2026 12:17:00 CEST | Press release
Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country's national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/ By connecting to Argentina's national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide. This service helps to enhance global travellers' travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom